The epidermal growth factor receptor-stat pathway in esophageal cancer

Cancer Journal

Volumn 7, Issue 2, 2001, Pages 108-111

  Schrump, D S ^a   Nguyen, D M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; STAT PROTEIN;

ESOPHAGUS CANCER; GENE EXPRESSION; HUMAN; NOTE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0035053332     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (21)

1. Strategies for molecular intervention in esophageal cancers and their precursor lesions
2. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: Mechanisms and implications
3. The level of tyrosine kinase activity regulates the expression of p21/WAF1 in cancer cells
4. Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma: Implication for the autocrine proliferation
5. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma
6. Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology
7. The role of STATs in transcriptional control and their impact on cellular function
8. STATs and gene regulation
9. Preface: STAT signaling
10. STATs in oncogenesis
11. Induction of p21 WAF1/ CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: Role of activated STAT3 signaling
12. Serine/threonine phosphorylation in cytokine signal transduction
13. Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor
14. STAT signaling in head and neck cancer
15. ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells
16. Progression of esophageal carcinoma by loss of EGF-STAT1 pathway
17. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture
18. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein
19. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors